Ypsomed India Private Ltd - Company Review
Ypsomed India Private Ltd - Company ReviewSummary
Ypsomed India Private Ltd (Ypsomed India), a subsidiary of Ypsomed Holding AG is a medical device company that offers a range of products and services for the treatment of diabetes. The company's products include pen needles, blood glucose measuring tools and other accessories. Its pen needles include penfine, clickfine, clickfine autoProtect and penfine classic; its accessories include Diabass, Needle Remover and mylife ACV; and its blood glucose tools include unio, pura X and safety lancets. Ypsomed India also offers advisory and dialog on diabetes. Its target treatment areas include Diabetes type 1 and Type 2, sequelae and gestational diabetes. The company offers product and services to patients, doctors and hospitals. Ypsomed India is headquartered in New Delhi, India.
This comprehensive company report of Ypsomed India Private Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.